Announcement

Collapse
No announcement yet.

RGN-259 - possibly available in England

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • RGN-259 - possibly available in England

    Seems RGN-259 could be soon available in England. According to some threads here:
    http://finance.yahoo.com/mb/forumvie...4dc4e42&page=1

    Though it just went through phase 2 and didn't met all endpoints (but FDA trials are not perfect at all), it could get green in England. Coz it should be safe and could be benefitial for some people, it could be approved. But because not complete clinical trials if it's approved it MUST be cheap then. And if approved in England, they would probably asked for approval EMA to be approved in the whole Europe.

    Right now Ikervis is also being analyzed by EMA, so there's possibility that it will be approved and available in Europe this year. So soon there could be 2 dry eye drugs available in Europe. And if this really happens, then maybe clinical trials will move more to Europe. And would be less strict than those in USA.

  • #2
    Looks like Ikervis will be really approved. Seems French authorities have forbidden prescribing Restasis (which I read was broadly prescribed there) and Ikervis should be prescribed instead.
    I remember reading here some patient's comments about Cyclokat (development name for Ikervis). According to his doctor it's much more efficient than Restasis, he even participated in clinical trials and claimed he had been able to recognize who had received placebo and who had received Cyclokat. So good it was. If I remember right, he was from Germany. so let's wait and hope.

    Comment

    Working...
    X